Abstract |
We investigated the expression of KIT (product of c-kit oncogene), gain-of-function mutations, and activation of its downstream signal transduction in human testicular cancers. KIT was expressed in 88% (22/25) of seminomas and in 44.4% (4/9) of non- seminomas compared to adjacent normal testicular tissue. Nine of the KIT-expressing seminomas had mutations (40.9%; 9/22) in the c-kit gene; two cases in exon 11 and 7 cases in exon 17. Two of these mutations in exon 17 were novel, and the other seven mutations were identical to the already known gain-of-function mutations which cause activation of KIT without ligand stem cell factor. All of the mutant KIT and 53.8% (7/13) of wild-type KIT were phosphorylated (activated) and associated with phosphorylated phosphatidylinositol 3-kinase (PI3K). Akt was also phosphorylated in these seminomas, suggesting that the KIT-PI3K-Akt pathway is activated in seminoma. These findings suggest that the KIT-PI3K-Akt pathway is constitutively activated in testicular germ cell tumors, due to overexpression of KIT protein and/or gain-of-function mutations in the c-kit gene.
|
Authors | Yasutomo Nakai, Norio Nonomura, Daizo Oka, Masayuki Shiba, Yasuyuki Arai, Masashi Nakayama, Hitoshi Inoue, Kazuo Nishimura, Katsuyuki Aozasa, Yoichi Mizutani, Tsuneharu Miki, Akihiko Okuyama |
Journal | Biochemical and biophysical research communications
(Biochem Biophys Res Commun)
Vol. 337
Issue 1
Pg. 289-96
(Nov 11 2005)
ISSN: 0006-291X [Print] United States |
PMID | 16188233
(Publication Type: Journal Article)
|
Chemical References |
- Phosphatidylinositol 3-Kinases
- Proto-Oncogene Proteins c-kit
|
Topics |
- Adult
- Aged
- Enzyme Activation
- Germinoma
(enzymology, genetics)
- Humans
- Male
- Middle Aged
- Mutation
- Phosphatidylinositol 3-Kinases
(metabolism)
- Proto-Oncogene Proteins c-kit
(genetics, metabolism)
- Seminoma
(enzymology, genetics)
- Signal Transduction
- Testicular Neoplasms
(enzymology, genetics)
|